Big Yields Are Easy to Find. These 4 Dividend Stocks Have Something Better

The article highlights four dividend stocks whose payouts it says are supported by visible cash generation: Enterprise Products Partners’ 6.07% yield is covered 1.9x by second-quarter distributable cash flow, while Enbridge yields 6.07%, J&J about 2.07%, and British American Tobacco about 6.20%. It cites Enterprise’s record adjusted EBITDA of $2.83B, Enbridge’s C$2.95B quarterly distributable cash flow, J&J’s expected free cash flow approaching $21B, and BAT’s cash-conversion record, while noting risks including leverage, competition, litigation and regulation. The piece is positive on dividend sustainability but describes company-specific vulnerabilities; it reports no market-wide event.

Analysis

The useful distinction is not headline yield but what can impair the cash stream. EPD and Enbridge diversify an income book away from consumer and healthcare demand, but they are not independent: both remain exposed to rates, permitting and the economics of North American energy flows. EPD’s growth-project pipeline may support cash-flow growth over a multi-year horizon; near term, normalization of the cited demand boost makes the next few quarters a test of underlying throughput. Enbridge’s leverage and CAD translation add balance-sheet and currency sensitivity, so its payout is less of a pure bond substitute than the article implies.

JNJ offers a different risk profile, but a low yield and strong recent share performance make it a defensive-growth holding, not a compelling income trade by yield alone. Monitor Stelara erosion, litigation and execution around the planned separation; any deterioration in guidance would challenge the quality premium. BTI’s valuation may compensate for regulatory exposure, but illicit-vape substitution can pressure the economics of its transition products even while legacy pricing supports cash. The affiliate-supported article’s cash-coverage comparisons are not directly comparable across partnership DCF, corporate free cash flow and EPS; verify current filings and guidance before sizing.

Over 1–3 months, rates, currency and quarterly cash-flow updates are the likely price drivers. Over 6–18 months, project execution, leverage reduction and JNJ’s separation matter more. The contrarian point: payout coverage can indicate dividend capacity without establishing attractive total-return upside; a stable payout does not prevent multiple compression.

Key Decisions for Investors

• Prefer EPD over Enbridge for incremental midstream exposure, but scale in rather than chase strength. Reassess if normalized cash flow no longer covers distributions comfortably, project costs or timing worsen, or leverage rises; do not treat both pipeline names as separate diversifiers.
• Keep JNJ as a quality/defensive holding rather than buying solely for income. Track updated product-growth and EPS guidance against Stelara erosion, litigation costs and separation execution; a guidance cut would falsify the defensive-growth case.
• Treat BTI as a higher-risk income position, not a bond proxy. Watch smokeless-product growth, illicit-vape competition, leverage progress and regulatory or tax developments; reduce the thesis if transition growth weakens while legacy pricing cannot offset it.
• Before acting on any yield comparison, reconcile each issuer’s latest reported distributable cash flow/free cash flow, payout definition, debt trajectory and currency exposure. If the objective is new income exposure, compare total-return sensitivity to rates and FX—not yield alone.